Nicotinamide Riboside Bai Takaita Agogon Epigenetik ba, Bincike Ya Gane
Idan ka fara shan ƙarin NAD+, kana bin tattaunawar rapamycin, ko kuma ka karanta game da senolytics, za ka iya jin cewa waɗannan abubuwan suna da tasiri. Amma wani sabon bincike na ƙwararru da aka wallafa a Frontiers in Genetics ya duba wane maganganu ne ke sauya agogon epigenetik na zamani a gwaje‑gwajen mutane. Nicotinamide riboside (NR), rapamycin, da senolytics ba su nuna wani tasiri ba. A gefe guda, motsa jiki, cin abincin ciyawa mai yawa, da maganin rage kolesterol sun rage agogon. Haka kuma wasu hanyoyin da ba a saba gani ba sun nuna tasiri.
Takardar da aka rubuta da taken "Turning Back Time" ta fito ne daga Alan Johnson na Tally Health da David Sinclair na Harvard Medical School. Sun tara ƙididdiga daga nazari 41 na gwaje‑gwajen mutane. Ga abin da marubutan suka gano, menene ma’anarsa, da abin da ba su gano ba.
Abin da Binciken Ya Gano Da Gaske
Agogon epigenetik suna auna shekarun jiki ta hanyar alamun methylation na DNA. Agogunan “na kalanda” su ne ke ƙididdige shekarun da aka haifa, yayin da agogunan ƙarni na gaba (epigenetic clocks) ke nuna yadda salon rayuwa, kiwon lafiya, da cututtuka ke sa shekarun jikin su bambanta da na kalanda. Bisa ga marubutan, waɗannan sabbin samfuran suna da alaƙa da haɗarin mutuwa saboda dalilai daban‑daban.
Marubutan suka wallafa jerin nazarce‑nazarcen kimiyya kuma suka zaɓi nazari 41 na mutane da suka ba da rahoto kan tasirin wani magani a kan aƙalla ɗayan agogon ƙarni na gaba. Sun tattara girman tasiri kuma suka kwatanta agogunan yadda ake amfani da su da yadda suke amsa ga maganganu.
Har yanzu marubutan suna ɗaukar agogunan epigenetik a matsayin samfuran biomarker da ke cikin bincike; rage agogo ba yana nufin tsawon rai ba.
Maganganu Da Suka Rage Shekarun Epigenetik
A takaitaccen rahoton, an gano waɗannan abubuwan suna da alaƙa da raguwa a shekarun epigenetik:
- Motsa jiki
- Abincin da ya ƙunshi ciyawa da ƙwayoyin tsire‑tsire
- Semaglutide (maganin GLP‑1 receptor agonist)
- Ƙuntata abinci
- Omega‑3 fatty acids
- Kayan kari na multivitamin‑multimineral
- Ketamine
- Jinin ƙashin mahaifa (umbilical cord plasma)
- Pitavastatin (maganin rage kolesterol)
Jerin ya haɗa da halaye na yau da kullum, magunguna da aka rubuta, kari, da hanyoyin gwaji na asibiti. Binciken ya kuma taɓa maganganun zamantakewa a cikin fadar sa.
Abin Mamaki: NR, Rapamycin, da Senolytics Ba Su Yi Komai Ba
Wannan shi ne sakamakon da ya fi daukar hankali. Nicotinamide riboside, rapamycin, senolytics, da wasu maganganu da dama ba su nuna wani tasiri ba a kan agogunan epigenetik.
Dukkaninsu suna cikin zaɓaɓɓun hanyoyin tsawon rai. NR sananne ne a matsayin kari na NAD+ precursor. Rapamycin yawan fitowa ne a tattaunawar anti‑aging. Senolytics kuwa na nufin kawar da sel‑sel da suka tsufa. Amma yawancin bayanan da ke goyon bayan su sun fito ne daga gwaje‑gwajen dabbobi da sel, yayin da wannan bincike ya mai da hankali kacokan kan masu jiki.
Akwai muhimman tambayoyi biyu da ya kamata a lura da su:
- “Ba a ga tasiri ba” ba yana nufin “babu fa’ida”. Wani sinadari na iya inganta lafiya ta hanyoyin da wadannan agogo ba su auna ba. Haka kuma, gwaje‑gwajen na iya kasancewa gajeru, ƙanana, ko ba su da tsari mai dacewa don sauya alamar methylation.
- Agogunan ba su zama ma’auni cikakke ba. Sauyinsu kan bambanta; marubuta sun kwatanta su don gano wane agogo ke da saurin amsa ga magani.
Ƙararrawa: Wasu Hanyoyi Na Hanzarta Tsufa
Binciken ya kuma nuna cewa plasmapheresis da wasu magunguna na iya hanzarta tsufar epigenetik. Plasmapheresis hanya ce da ake tace ko musanya plasma na jini. A wani ɓangare, an samu sakamakon cewa jinin ƙashin mahaifa ya rage shekarun epigenetik. Ko wannan yana nuni da abin da aka cire, abin da aka ƙara, ko kuma auna ne daban‑daban, ba a fayyace ba. Wannan yana tunatar da mu cewa “sabunta jini” ba ra’ayi guda ba ne.
Abubuwan Da Za A Iya Aiwatar Da Su
Takaitaccen rahoton ba ya ba da ƙima, lokacin amfani, ko tsawon lokacin da ya dace a yiwa kowanne magani. Wadannan bayanai suna a teburin takardar asali, don haka a duba su kafin a ɗauki mataki. Ga wasu shawarwari da za su iya taimaka:
Abubuwan Da Ba Su Da Hadari Kuma Suna Iya Aiwatar Da Kowa
- Motsa jiki da cin abincin ciyawa mai yawa: Waɗannan su ne abubuwan da suka fi ƙarancin haɗari a jerin. Kowa da ya sami izinin yin motsa jiki na iya fara. Mutanen da ke da matsalolin lafiya su nemi shawara daga likita.
- Omega‑3 da multivitamin‑multimineral: Kari ne da ake samu a kasuwa; a duba ƙimar da aka yi amfani da ita a gwaje‑gwaje. Waɗanda ke shan maganin rage zubar jini su tambayi likita kafin su ƙara manyan doz ɗin omega‑3.
- Ƙuntata abinci: Ba ya dace da kowa ba. Waɗanda ke fama da ƙasaƙƙen ƙiba, masu ciki, tsofaffi marasa ƙarfi, ko waɗanda suka sha fama da damuwar abinci su guje shi.
Magunguna Da Za Su Buƙaci Takardar Doka da Kulawar Likita
- Semaglutide: Magani ne da likita ke rubutawa don wasu cututtuka. Binciken ba ya goyon bayan amfani da shi kawai don juya agogo.
- Pitavastatin: Statin ne da ake amfani da shi don rage kolesterol; ya kamata a tattauna shi a cikin batun haɗarin zuciya, ba don neman rage agogo ba.
- Ketamine: Ana ba da shi ne a ƙarƙashin kulawar likita; ba kari na tsawon rai ba ne, kuma wannan sakamakon ba ya zama dalili don gwajin kai.
Hanyoyin Gwaji
- Jinin ƙashin mahaifa da plasmapheresis: Suna cikin fannin binciken asibiti. Saboda plasmapheresis na iya hanzarta tsufar epigenetik, a guji talla da ke alkawarin sabunta jini.
Waɗanda Ya Kamata Su Sake Tunani Kan Yin Kuɗi A Kan NR Mutanen da ke kashe kuɗi mai yawa a kan NR don rage shekarun epigenetik su sani cewa hujjojin da aka yi nazari a kan mutane ba su nuna tasiri a kan waɗannan agogunan ba. Wannan ba yana nufin NR ba ne da haɗari ko ba shi da amfani a wasu fannoni, amma bukatar a tantance muhimmin abin da ake nema.
Yanayin Rashin Daidaito Na Ƙwararru
Masu karatu su duba sha’awar marubuta. Alan Johnson yana aiki a Tally Health, kamfani da ke sayar da gwajin shekarun epigenetik. David Sinclair ya bayyana cewa yana da hannun jari da wasu ƙawance a kamfanoni da dama na tsawon rai: EdenRoc Sciences, Life Biosciences, NucleicAI, Paradigm88, da Tally Health. Kamfanoni masu sha’awar sayar da gwaji suna son ganin agogunan suna da ma’ana ta kasuwanci, don haka a duba yadda aka fassara sakamakon. Binciken ya nuna rashin tasiri ga manyan sinadarai na tsawon rai; wannan ba ya kawar da rikice‑rikice, amma yana nuna buƙatar yin hankali kan “kayan talla”.
Ƙarshe
Karatu mafi sahihi na wannan bincike shi ne a hankali. Wasu maganganu—musamman waɗanda suka shafi halaye na yau da kullum—suna da alaƙa da rage shekarun epigenetik na ƙarni na gaba a gwaje‑gwajen mutane. Wasu sinadarai da aka yi wa mutane tasiri sosai ba su nuna tasiri a kan waɗannan agogunan ba. Agogunan epigenetik har yanzu suna cikin bincike, kuma alamar da ba a kammala ba ba ta nufin tabbacin tsawon rai ba. Kafin ka canza tsarin rayuwarka bisa wani sabon magani, karanta cikakken bayanin gwaje‑gwaje da sakamakon da aka samu.
